Agile Growth (AGGR) 10-Q 9 Aug 22 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 09, 2022
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Entity File Number	001-40186
Entity Registrant Name	AGILE GROWTH CORP.
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1562072
Entity Address, Address Line One	Riverside Center
Entity Address, Address Line Two	275 Grove Street, Suite 2-400
Entity Address, City or Town	Newton
Entity Address State Or Province	MA
Entity Address, Postal Zip Code	02466
City Area Code	617
Local Phone Number	663-5997
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001842329
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Document and Entity Information
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	AGGRU
Security Exchange Name	NASDAQ
Class A ordinary shares included as part of the units
Document and Entity Information
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	AGGR
Security Exchange Name	NASDAQ
Warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Document and Entity Information
Title of 12(b) Security	Warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	AGGRW
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Document and Entity Information
Entity Common Stock, Shares Outstanding		31,000,000
Class B Ordinary Shares
Document and Entity Information
Entity Common Stock, Shares Outstanding		7,750,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 200,026	$ 684,467
Prepaid expenses	424,380	502,361
Total current assets	624,406	1,186,828
Non-current assets:
Investments held in Trust Account	310,442,804	310,016,344
Prepaid expenses (non-current)		89,685
Total non-current assets	310,442,804	310,106,029
Total Assets	311,067,210	311,292,857
Current liabilities:
Accounts payable	12,027	175,448
Working Capital Loan - related party	250,000
Accrued expenses	1,474,954	1,401,688
Total current liabilities	1,736,981	1,577,136
Deferred underwriting commissions	10,850,000	10,850,000
Derivative warrant liabilities	3,306,670	10,581,330
Total liabilities	15,893,651	23,008,466
Commitments and Contingencies
Shareholders' Deficit:
Preference shares, $0.0001 par value 1,000,000 shares authorized none issued and outstanding
Additional paid-in capital
Accumulated deficit	(15,170,020)	(21,716,384)
Total shareholders' deficit	(15,169,245)	(21,715,609)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	311,067,210	311,292,857
Class A Common Stock Subject to Redemption
Current liabilities:
Class A ordinary shares, $0.0001 par value; 31,000,000 shares at redemption value of $10.01 and $10.00 per share as of June 30, 2022 and December 31, 2021, respectively	310,342,804	310,000,000
Class A Common Stock Not Subject to Redemption
Shareholders' Deficit:
Ordinary shares
Class B Ordinary Shares
Shareholders' Deficit:
Ordinary shares	$ 775	$ 775

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock Subject to Redemption
Temporary Equity, par value (in dollars per share)	$ 0.0001	$ 0.0001
Temporary equity, shares outstanding	31,000,000	31,000,000
Redemption value (in dollars per share)	$ 10.01	$ 10
Class A Common Stock Not Subject to Redemption
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	400,000,000	400,000,000
Common shares, shares issued	0	0
Class B Ordinary Shares
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	40,000,000	40,000,000
Common shares, shares issued	7,750,000	7,750,000
Common shares, shares outstanding	7,750,000	7,750,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2022
General and administrative expenses	$ 282,153	$ 322,980	$ 487,032	$ 651,952
General and administrative expenses- related party	40,000	120,000	160,000	160,000
Loss from operations	(322,153)	(442,980)	(647,032)	(811,952)
Change in fair value of derivative warrant liabilities	1,653,330	(4,960,000)	(826,670)	7,274,660
Financing costs allocated to warrants			(533,950)
Income from investments held in Trust Account	406,099	4,629	5,433	426,460
Net income (loss)	$ 1,737,276	$ (5,398,351)	$ (2,002,219)	$ 6,889,168
Class A Ordinary Shares
Weighted average shares outstanding, basic	31,000,000	31,000,000	21,347,826	31,000,000
Weighted average shares outstanding, diluted	31,000,000	31,000,000	21,347,826	31,000,000
Basic net income (loss) per share	$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Diluted net income (loss) per share	$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Class B Ordinary Shares
Weighted average shares outstanding, basic	7,750,000	7,500,000	7,666,149	7,750,000
Weighted average shares outstanding, diluted	7,750,000	7,500,000	7,750,000	7,750,000
Basic net income (loss) per share	$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Diluted net income (loss) per share	$ 0.04	$ (0.14)	$ (0.07)	$ 0.18

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Ordinary Shares Class A Ordinary Shares	Ordinary Shares Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Jan. 20, 2021	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Jan. 20, 2021	0	0
Increase (Decrease) in Stockholders' Equity
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 862	24,138		25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	8,625,000
Excess cash received over fair value of private placement warrants	$ 0	$ 0	3,720,000		3,720,000
Remeasurement of Class A ordinary shares subject to possible redemption amount	0	0	(3,744,138)	(22,700,067)	(26,444,205)
Net income (loss)	0	0		3,396,132	3,396,132
Ending balance at Mar. 31, 2021	$ 0	$ 862		(19,303,935)	(19,303,073)
Ending balance (in shares) at Mar. 31, 2021	0	8,625,000
Beginning balance at Jan. 20, 2021	$ 0	$ 0	0	0	0
Beginning balance (in shares) at Jan. 20, 2021	0	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)					(2,002,219)
Ending balance at Jun. 30, 2021	$ 0	$ 775		(24,702,199)	(24,701,424)
Ending balance (in shares) at Jun. 30, 2021	0	7,750,000
Beginning balance at Mar. 31, 2021	$ 0	$ 862		(19,303,935)	(19,303,073)
Beginning balance (in shares) at Mar. 31, 2021	0	8,625,000
Increase (Decrease) in Stockholders' Equity
Forfeiture of Class B ordinary shares	$ 0	$ (87)	87
Forfeiture of Class B ordinary shares (in shares)		(875,000)
Subsequent measurement of Class A ordinary shares subject to redemption against additional paid-in capital	0	$ 0	$ (87)	87
Net income (loss)	0	0		(5,398,351)	(5,398,351)
Ending balance at Jun. 30, 2021	$ 0	$ 775		(24,702,199)	(24,701,424)
Ending balance (in shares) at Jun. 30, 2021	0	7,750,000
Beginning balance at Dec. 31, 2021		$ 775		(21,716,384)	(21,715,609)
Beginning balance (in shares) at Dec. 31, 2021		7,750,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)				5,151,892	5,151,892
Ending balance at Mar. 31, 2022		$ 775		(16,564,492)	(16,563,717)
Ending balance (in shares) at Mar. 31, 2022		7,750,000
Beginning balance at Dec. 31, 2021		$ 775		(21,716,384)	(21,715,609)
Beginning balance (in shares) at Dec. 31, 2021		7,750,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)					6,889,168
Ending balance at Jun. 30, 2022		$ 775		(15,170,020)	(15,169,245)
Ending balance (in shares) at Jun. 30, 2022		7,750,000
Beginning balance at Mar. 31, 2022		$ 775		(16,564,492)	(16,563,717)
Beginning balance (in shares) at Mar. 31, 2022		7,750,000
Increase (Decrease) in Stockholders' Equity
Deemed dividend - increase in redemption value of Class A ordinary shares subject to possible redemption				(342,804)	(342,804)
Net income (loss)				1,737,276	1,737,276
Ending balance at Jun. 30, 2022		$ 775		$ (15,170,020)	$ (15,169,245)
Ending balance (in shares) at Jun. 30, 2022		7,750,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	5 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2022
Cash Flows from Operating Activities
Net income	$ (2,002,219)	$ 6,889,168
Adjustments to reconcile net income to net cash used in operating activities:
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares	25,000
General and administrative expenses paid by related party under note payable	5,108
Change in fair value of derivative warrant liabilities	826,670	(7,274,660)
Financing costs - derivative warrant liabilities	533,950
Income from investments held in Trust Account	(5,434)	(426,460)
Changes in operating assets and liabilities:
Prepaid expenses	(812,215)	167,666
Accounts payable	8,195	(163,421)
Accrued expenses	84,122	73,266
Net cash used in operating activities	(1,336,823)	(734,441)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(310,000,000)
Net cash used in investing activities	(310,000,000)
Cash Flows from Financing Activities
Working Capital Loan - related party		250,000
Proceeds received from initial public offering, gross	310,000,000
Proceeds received from private placement	9,300,000
Offering costs paid	(6,646,644)
Repayment of note payable to related party	(100,247)
Net cash provided by financing activities	312,553,109	250,000
Net change in cash	1,216,286	(484,441)
Cash - beginning of the period	0	684,467
Cash - ending of the period	1,216,286	200,026
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accounts payable	920
Offering costs included in accrued expenses	85,450
Offering costs paid by related party under note payable	95,139
Deferred underwriting commissions in connection with the initial public offering	10,850,000
Remeasurement of Class A ordinary shares subject to possible redemption amount	$ (26,444,205)	$ (342,804)

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2022
Description of Organization and Business Operations
Description of Organization and Business Operations	Note 1 — Description of Organization and Business Operations Agile Growth Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, recapitalization or similar business combination with one or more businesses or entities that the Company has not yet identified (“Business Combination”). As of June 30, 2022, the Company had not yet commenced substantive operations. All activity for the period from January 21, 2021 (inception) through June 30, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and activities in connection with pursuing an initial Business Combination. The Company will not The Company’s sponsor is Agile Growth Sponsor, LLC, a Delaware limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on March 9, 2021. On March 12, 2021, the Company consummated its Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, of which $10.5 million was for deferred underwriting commissions (see Note 5). On March 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 1,000,000 Units (the “Over-Allotment Units”), generating gross proceeds of approximately $10.0 million, and we incurred additional offering costs of $550,000 (of which $350,000 was for deferred underwriting fees) (the “Over-Allotment”). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,066,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $9.1 million (see Note 4). Simultaneously with the closing of the Over-Allotment on March 16, 2021, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 133,333 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of $200,000. Upon the closing of the Initial Public Offering and the Private Placement on March 12, 2021, $300.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. In connection with the consummation of the Over-Allotment on March 16, 2021, additional net proceeds of $10.0 million were deposited into the Trust Account, for a total of $310.0 million in the Trust Account. The Company’s management has broad discretion with respect to the specific application of the net proceeds of our Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (at $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering without the prior consent of the Company. The Company’s Sponsor, executive officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would modify the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 12, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. ​

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Summary of Significant Accounting Policies	​ Note 2 — Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 25, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Liquidity and Going Concern As of June 30, 2022, we had approximately $200,000 in our operating bank account and working capital deficit of approximately $1.1 million. Prior to the completion of the Initial Public Offering, our liquidity was satisfied through a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 4), a loan of approximately $100,000 from the Sponsor pursuant to the Note (as defined in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on March 18, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of June 30, 2022, there was $250,000 outstanding under Working Capital Loans. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 12, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. Risks and uncertainties Management is currently evaluating the impact of the COVID-19 global pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2022 and December 31, 2021 held outside of the Trust Account. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including funded loans and issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments and embedded derivatives, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The Public Warrants and Private Placement Warrants were initially measured at fair value using a binomial lattice model in a risk-neutral framework. As of June 30, 2022 and December 31, 2021, the fair value of the Public Warrants is based on the listed price in an active market for such warrants, and the fair value of the Private Placement Warrants is measured using a binomial lattice model in a risk-neutral framework. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A ordinary shares issued were charged to the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 31,000,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. Subsequent changes result from income and losses on investments held in the Trust Account that would be distributed to the Class A ordinary shareholders upon redemption. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Income per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the Over-Allotment) and the Private Placement Warrants to purchase an aggregate of 16,533,333 Class A ordinary shares in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three and six months ended June 30, 2022, the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021. Remeasurement associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months ​ For The Three Months ​ ​ Ended June 30, 2022 ​ Ended June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 1,389,821 ​ $ 347,455 ​ $ (4,346,724) ​ $ (1,051,627) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 31,000,000 ​ ​ 7,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.04 ​ $ 0.04 $ (0.14) ​ $ (0.14) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Six Months ​ For The Period From January 21, 2021 ​ ​ Ended June 30, 2022 ​ (Inception) Through June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss), basic ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,473,187) ​ $ (529,032) Allocation of net income (loss), diluted ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,468,942) ​ $ (533,277) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,666,149 Diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,750,000 Basic net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 ​ $ (0.07) ​ $ (0.07) Diluted net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 $ (0.07) ​ $ (0.07) ​ Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2022
Initial Public Offering
Initial Public Offering	Note 3 — Initial Public Offering On March 12, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, of which $10.5 million was for deferred underwriting commissions. On March 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 1,000,000 Over-Allotment Units, generating gross proceeds of approximately $10.0 million, and we incurred additional offering costs of $550,000 (of which $350,000 was for deferred underwriting fees). Each Unit consists of one Class A ordinary share and one

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On January 23, 2021, the Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional Units was not exercised in full by the underwriters, so that the Founder Shares will represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On March 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 1,000,000 Over-Allotment Units; thus, only 875,000 Class B ordinary shares remained subject to forfeiture as of such date. On April 23, 2021, 875,000 Class B ordinary shares were forfeited, resulting in the Sponsor holding 7,750,000 Class B ordinary shares as of such date. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 30 Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 6,066,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $9.1 million. Simultaneously with the closing of the Over-Allotment on March 16, 2021, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 133,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant by the Sponsor, generating gross proceeds to the Company of $200,000. Each whole Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable except as described in Note 7 and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On March 12, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. As of March 12, 2021, the Company borrowed approximately $100,000 under the Note. The Company fully repaid such amount on March 18, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, certain of the Company’s officers and directors or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. There were no borrowings under a Working Capital Loan as of December 31, 2021. On May 16, 2022, the Sponsor agreed to loan the Company $250,000 under a non-interest bearing promissory note (the “Working Capital Loan”). The principal balance of the Working Capital Loan is repayable on the consummation of the initial Business Combination. If a Business Combination is not consummated, the Working Capital Loan will not be repaid and all amounts owed thereunder will be forgiven except to the extent that the Company has funds available to it outside of the Trust Account. Upon consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the outstanding principal balance into Private Placement Warrants at a price of $1.50 per Private Placement Warrant. The conversion option is an embedded derivative under ASC 815 that is required to be separately measured at fair value with subsequent changes in fair value recognized in Company’s condensed statements of operations each reporting period until the Working Capital Loan is repaid, converted or terminated. The embedded conversion option is valued in a binomial lattice model framework. The Company’s current stock price is used as the starting point with each terminal node commensurate with the term to initial Business Combination and the value of the warrants is compared to the conversion price of $1.50. The likelihood of an initial Business Combination occurring is accounted for through using the volatility estimate implied from the traded price of the Company’s Public Warrants. Given the resulting low implied volatility, the stock price in relation to the conversion price, and the implied probability of completing an initial Business Combination, the fair value of the conversion option was determined to be de minimis as of May 16, 2022 and June 30, 2022. Administrative Support Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor up to $40,000 per month for office space and administrative, support and consulting services provided to members of the management team or to the Company. For the three months ended June 30, 2022 and 2021, the Company incurred $40,000 and $120,000 of such expenses, respectively, which are recognized as general and administrative expenses - related party in the accompanying condensed statements of operations. For the six months ended June 30, 2022 and for the period from January 21 (inception) through June 30, 2021, the Company incurred $160,000 and $160,000 of such expenses, respectively, which are recognized as general and administrative expenses – related party in the accompanying condensed statements of operations. In addition, the Sponsor, officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers or directors, or their affiliates. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies
Commitments and Contingencies	Note 5 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the prospectus in connection with the Initial Public Offering to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On March 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional 1,000,000 Over-Allotment Units. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In connection with the consummation of the Over-Allotment on March 16, 2021, the underwriters were entitled to an additional fee of $200,000 paid upon closing, and $350,000 in deferred underwriting commissions. Consulting Fees The Company entered into an engagement agreement to obtain certain advisory services, pursuant to which the engaged consultant agreed to defer their fees and have payment of such fees be solely contingent on the Company closing an initial Business Combination. As of June 30, 2022 and December 31, 2021, the Company has incurred $732,600 in contingent fees pursuant to the agreement. The Company will recognize an expense for these services when the performance trigger is considered probable, which in this case will occur upon closing of an initial Business Combination.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	6 Months Ended
	Jun. 30, 2022
Class A Ordinary Shares Subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption	Note 6 — Class A Ordinary Shares Subject to Possible Redemption ​ The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 31,000,000 Class A ordinary shares outstanding, all of which were subject to possible redemption and classified in temporary equity. The Class A ordinary shares issued in the Initial Public Offering and issued as part of the Over-Allotment Units were recognized in Class A ordinary shares stock subject to possible redemption as follows: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering and sale of Over-Allotment Units $ 310,000,000 Less: ​ ​ Fair value of Public Warrants at issuance ​ (9,300,000) Offering costs allocated to Class A ordinary shares subject to possible redemption ​ (17,144,205) Plus: ​ ​ Accretion on Class A ordinary shares subject to possible redemption amount ​ 26,444,205 Class A ordinary shares subject to possible redemption ​ ​ 310,000,000 Remeasurement accretion on Class A ordinary shares subject to possible redemption amount ​ ​ 342,804 Class A ordinary shares subject to possible redemption ​ $ 310,342,804 ​

Derivative Warrant Liabilities

Derivative Warrant Liabilities	6 Months Ended
	Jun. 30, 2022
Derivative Warrant Liabilities
Derivative Warrant Liabilities	Note 7 — Derivative Warrant Liabilities As of June 30, 2022 and December 31, 2021, the Company had an aggregate of 16,533,333 warrants outstanding, comprised of 10,333,333 Public Warrants and 6,200,000 Private Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later than 20 60 The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described in the final prospectus filed with the SEC on March 11, 2021 under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described in such final prospectus under the caption “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 : Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): ​ ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 : Once the warrants become exercisable, the Company may redeem the outstanding warrants: ​ ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; and ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of the Class A ordinary shares for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of the Company’s Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

Shareholders' Deficit

Shareholders' Deficit	6 Months Ended
	Jun. 30, 2022
Shareholders' Deficit
Shareholders' Deficit	Note 8 — Shareholders’ Deficit Preference Shares— Class A Ordinary Shares— Class B Ordinary Shares— Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares, which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions if the Company does not consummate an initial Business Combination, at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Measurements
Fair Value Measurements	Note 9 — Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - money market fund $ 310,442,804 $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities - Public warrants ​ $ 2,066,670 ​ $ — ​ $ — Derivative warrant liabilities - Private placement warrants ​ $ — ​ $ 1,240,000 ​ $ — ​ December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - money market fund $ 310,016,344 $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities - Public warrants ​ $ 6,613,330 ​ $ — ​ $ — Derivative warrant liabilities - Private placement warrants ​ $ — ​ $ 3,968,000 ​ $ — ​ Transfers to or from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement in April 2021, as the Public Warrants were separately listed and traded in an active market during the period. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 measurement to a Level 2 measurement in April 2021, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. The fair value of the Public Warrants and the Private Placement Warrants was initially measured at fair value using a binomial lattice model in a risk-neutral framework. As of June 30, 2022 and December 31, 2021, the fair value of the Public Warrants is based on the listed price in an active market for such warrants, and the fair value of the Private Placement Warrants is measured using significant observable market inputs. For the three months ended June 30, 2022 and 2021, the Company recognized non-operating gains/(losses) of approximately $1.7 million and ($5.0 million), respectively, in the condensed statements of operations resulting from a decrease/(increase) in the fair value of derivative warrant liabilities. For the six months ended June 30, 2022 and for the period from January 21 (inception) through June 30, 2021, the Company recognized non-operating gains/(losses) of approximately $7.3 million and ($0.8 million), respectively, in the condensed statements of operations resulting from a decrease/(increase) in the fair value of derivative warrant liabilities. The initial estimated fair value of the Public Warrants and the Private Placement Warrants was determined using Level 3 inputs. Inherent in a binomial lattice model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s ordinary stock that matches the expected remaining life of the warrants. The risk-free The following table provides quantitative information regarding Level 3 fair value measurements used to estimate the fair value of Public and Private Placement Warrants inputs at their initial measurement dates: ​ ​ ​ ​ ​ ​ ​ March 12, 2021 (initial ​ ​ measurement) and ​ ​ ​ March 16, 2021 (over- ​ ​ ​ allotment exercise) ​ Stock price ​ $ 9.70 ​ Volatility ​ 14.0 % Term to M&A ​ 1.0 ​ Risk-free rate ​ 1.08 % ​ The change in the fair value of the derivative warrant liabilities ​ ​ ​ ​ ​ Derivative warrant liabilities at January 21, 2021 (inception) $ — Issuance of Public and Private Placement Warrants at March 12, 2021 ​ ​ 14,460,000 Issuance of Public and Private Placement Warrants at March 16, 2021 ​ 420,000 Change in fair value of derivative warrant liabilities ​ ​ (4,133,330) Transfer of Public Warrants to Level 1 ​ ​ (6,716,670) Transfer of Private Placement Warrants to Level 2 ​ ​ (4,030,000) Derivative warrant liabilities at June 30, 2021 ​ $ — ​

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 25, 2022, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Liquidity and Going Concern	Liquidity and Going Concern As of June 30, 2022, we had approximately $200,000 in our operating bank account and working capital deficit of approximately $1.1 million. Prior to the completion of the Initial Public Offering, our liquidity was satisfied through a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 4), a loan of approximately $100,000 from the Sponsor pursuant to the Note (as defined in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on March 18, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of June 30, 2022, there was $250,000 outstanding under Working Capital Loans. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 12, 2023. The condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
Risks and uncertainties	Risks and uncertainties Management is currently evaluating the impact of the COVID-19 global pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2022 and December 31, 2021 held outside of the Trust Account.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of June 30, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the condensed balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Liabilities	Derivative Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including funded loans and issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments and embedded derivatives, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The Public Warrants and Private Placement Warrants were initially measured at fair value using a binomial lattice model in a risk-neutral framework. As of June 30, 2022 and December 31, 2021, the fair value of the Public Warrants is based on the listed price in an active market for such warrants, and the fair value of the Private Placement Warrants is measured using a binomial lattice model in a risk-neutral framework.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A ordinary shares issued were charged to the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 31,000,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. Subsequent changes result from income and losses on investments held in the Trust Account that would be distributed to the Class A ordinary shareholders upon redemption.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Income per Ordinary Shares	Net Income per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the Over-Allotment) and the Private Placement Warrants to purchase an aggregate of 16,533,333 Class A ordinary shares in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per share is the same as basic net income per share for the three and six months ended June 30, 2022, the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021. Remeasurement associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The Company has considered the effect of Class B ordinary shares that were excluded from weighted average number as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months ​ For The Three Months ​ ​ Ended June 30, 2022 ​ Ended June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 1,389,821 ​ $ 347,455 ​ $ (4,346,724) ​ $ (1,051,627) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 31,000,000 ​ ​ 7,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.04 ​ $ 0.04 $ (0.14) ​ $ (0.14) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Six Months ​ For The Period From January 21, 2021 ​ ​ Ended June 30, 2022 ​ (Inception) Through June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss), basic ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,473,187) ​ $ (529,032) Allocation of net income (loss), diluted ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,468,942) ​ $ (533,277) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,666,149 Diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,750,000 Basic net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 ​ $ (0.07) ​ $ (0.07) Diluted net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 $ (0.07) ​ $ (0.07)
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Basis of Presentation and Summary of Significant Accounting Policies
Schedule of basic and diluted net income per ordinary share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Three Months ​ For The Three Months ​ ​ Ended June 30, 2022 ​ Ended June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 1,389,821 ​ $ 347,455 ​ $ (4,346,724) ​ $ (1,051,627) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 31,000,000 ​ ​ 7,500,000 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted net income (loss) per ordinary share ​ $ 0.04 ​ $ 0.04 $ (0.14) ​ $ (0.14) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For The Six Months ​ For The Period From January 21, 2021 ​ ​ Ended June 30, 2022 ​ (Inception) Through June 30, 2021 ​ Class A Class B Class A Class B Basic and diluted net income per ordinary share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss), basic ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,473,187) ​ $ (529,032) Allocation of net income (loss), diluted ​ $ 5,511,335 ​ $ 1,377,834 ​ $ (1,468,942) ​ $ (533,277) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,666,149 Diluted weighted average ordinary shares outstanding ​ ​ 31,000,000 ​ ​ 7,750,000 ​ ​ 21,347,826 ​ ​ 7,750,000 Basic net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 ​ $ (0.07) ​ $ (0.07) Diluted net income (loss) per ordinary share ​ $ 0.18 ​ $ 0.18 $ (0.07) ​ $ (0.07)

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	6 Months Ended
	Jun. 30, 2022
Class A Ordinary Shares Subject to Possible Redemption
Schedule of Class A ordinary shares stock subject to possible redemption	The Class A ordinary shares issued in the Initial Public Offering and issued as part of the Over-Allotment Units were recognized in Class A ordinary shares stock subject to possible redemption as follows: ​ ​ ​ ​ ​ Gross proceeds from Initial Public Offering and sale of Over-Allotment Units $ 310,000,000 Less: ​ ​ Fair value of Public Warrants at issuance ​ (9,300,000) Offering costs allocated to Class A ordinary shares subject to possible redemption ​ (17,144,205) Plus: ​ ​ Accretion on Class A ordinary shares subject to possible redemption amount ​ 26,444,205 Class A ordinary shares subject to possible redemption ​ ​ 310,000,000 Remeasurement accretion on Class A ordinary shares subject to possible redemption amount ​ ​ 342,804 Class A ordinary shares subject to possible redemption ​ $ 310,342,804

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Measurements
Schedule of Company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - money market fund $ 310,442,804 $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities - Public warrants ​ $ 2,066,670 ​ $ — ​ $ — Derivative warrant liabilities - Private placement warrants ​ $ — ​ $ 1,240,000 ​ $ — ​ December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Active Significant Other Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account - money market fund $ 310,016,344 $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative warrant liabilities - Public warrants ​ $ 6,613,330 ​ $ — ​ $ — Derivative warrant liabilities - Private placement warrants ​ $ — ​ $ 3,968,000 ​ $ — ​
Schedule of quantitative information regarding Level 3 fair value measurements inputs	The following table provides quantitative information regarding Level 3 fair value measurements used to estimate the fair value of Public and Private Placement Warrants inputs at their initial measurement dates: ​ ​ ​ ​ ​ ​ ​ March 12, 2021 (initial ​ ​ measurement) and ​ ​ ​ March 16, 2021 (over- ​ ​ ​ allotment exercise) ​ Stock price ​ $ 9.70 ​ Volatility ​ 14.0 % Term to M&A ​ 1.0 ​ Risk-free rate ​ 1.08 % ​
Schedule of change in the fair value of the warrant liabilities	The change in the fair value of the derivative warrant liabilities ​ ​ ​ ​ ​ Derivative warrant liabilities at January 21, 2021 (inception) $ — Issuance of Public and Private Placement Warrants at March 12, 2021 ​ ​ 14,460,000 Issuance of Public and Private Placement Warrants at March 16, 2021 ​ 420,000 Change in fair value of derivative warrant liabilities ​ ​ (4,133,330) Transfer of Public Warrants to Level 1 ​ ​ (6,716,670) Transfer of Private Placement Warrants to Level 2 ​ ​ (4,030,000) Derivative warrant liabilities at June 30, 2021 ​ $ —

Description of Organization a_2

Description of Organization and Business Operations - Summary (Details)			5 Months Ended	6 Months Ended
	Mar. 16, 2021 USD ($) shares	Mar. 12, 2021 USD ($) item $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Description of Organization and Business Operations
Revenues				$ 0
Proceeds received from initial public offering, gross			$ 310,000,000
Offering costs paid			6,646,644
Investment of cash into Trust Account		$ 300,000,000	$ 310,000,000
Investments held in Trust Account	$ 310,000,000			310,442,804	$ 310,016,344
Condition for future business combination number of businesses minimum | item		1
Condition for future business combination use of proceeds percentage		80%
Loans From Working Capital				$ 250,000
Duration Of Combination Period				24 months
Initial Public Offering.
Description of Organization and Business Operations
Units issued (in shares) | shares		30,000,000
Purchase price, per unit | $ / shares		$ 10
Proceeds received from initial public offering, gross		$ 300,000,000
Offering costs paid		17,100,000
Deferred underwriting costs		$ 10,500,000
Threshold percentage of outstanding voting securities of target to be acquired by post transaction company to complete business combination		50
Minimum net tangible assets upon consummation of business combination				$ 5,000,001
Threshold percentage of public shares subject to redemption without company prior written consent				15%
Percentage of public shares which must be redeemed if entity does not complete a Business Combination				100%
Threshold Business Days For Redemption Of Public Shares				10 days
Maximum interest income to be used to pay dissolution expenses				$ 100,000
Over-allotment option
Description of Organization and Business Operations
Units issued (in shares) | shares	1,000,000	4,500,000
Proceeds received from initial public offering, gross	$ 10,000,000
Offering costs paid	550,000
Deferred underwriting costs	350,000
Investment of cash into Trust Account	$ 10,000,000
Over-allotment option | Private Placement Warrants
Description of Organization and Business Operations
Sale of Private Placement Warrants (in shares) | shares	133,333
Proceeds from sale of Private Placement Warrants	$ 200,000
Private Placement | Private Placement Warrants
Description of Organization and Business Operations
Sale of Private Placement Warrants (in shares) | shares		6,066,667
Price of warrant | $ / shares		$ 1.50
Proceeds from sale of Private Placement Warrants		$ 9,100,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)			3 Months Ended		5 Months Ended	6 Months Ended
	Mar. 12, 2021	Jan. 23, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2022	Dec. 31, 2021
Basis of Presentation and Summary of Significant Accounting Policies
Amount in operating bank accounts						$ 200,000
Working capital deficit						1,100,000
Cash equivalents			$ 0			0	$ 0
Unrecognized tax benefits accrued for interest and penalties			0			0	0
Unrecognized tax benefits			0			0	$ 0
Working capital loan outstanding			250,000			250,000
Class A Ordinary Shares
Numerator:
Allocation of net income, basic			1,389,821	$ (4,346,724)	$ (1,473,187)	5,511,335
Allocation of net income, diluted			$ 1,389,821	$ (4,346,724)	$ (1,468,942)	$ 5,511,335
Denominator:
Basic weighted average ordinary shares outstanding			31,000,000	31,000,000	21,347,826	31,000,000
Diluted weighted average ordinary shares outstanding			31,000,000	31,000,000	21,347,826	31,000,000
Basic net income per ordinary share			$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Diluted net income per ordinary share			$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Class A Common Stock Subject to Redemption
Basis of Presentation and Summary of Significant Accounting Policies
Class A ordinary shares subject to possible redemption			31,000,000			31,000,000	31,000,000
Class A Common Stock Not Subject to Redemption
Basis of Presentation and Summary of Significant Accounting Policies
Anti-dilutive securities attributable to warrants (in shares)						16,533,333
Class B Ordinary Shares
Numerator:
Allocation of net income, basic			$ 347,455	$ (1,051,627)	$ (529,032)	$ 1,377,834
Allocation of net income, diluted			$ 347,455	$ (1,051,621)	$ (533,277)	$ 1,377,834
Denominator:
Basic weighted average ordinary shares outstanding			7,750,000	7,500,000	7,666,149	7,750,000
Diluted weighted average ordinary shares outstanding			7,750,000	7,500,000	7,750,000	7,750,000
Basic net income per ordinary share			$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Diluted net income per ordinary share			$ 0.04	$ (0.14)	$ (0.07)	$ 0.18
Related Party Loans
Basis of Presentation and Summary of Significant Accounting Policies
Loan from sponsor	$ 100,000
Sponsor | Class B Ordinary Shares
Basis of Presentation and Summary of Significant Accounting Policies
Expenses paid by Sponsor on behalf of the Company		$ 25,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)			5 Months Ended	6 Months Ended
	Mar. 16, 2021	Mar. 12, 2021	Jun. 30, 2021	Jun. 30, 2022
Initial Public Offering
Proceeds received from initial public offering, gross			$ 310,000,000
Offering costs paid			$ (6,646,644)
Public Warrants
Initial Public Offering
Number of warrants in a unit				0.33
Exercise price of warrants				$ 11.50
Initial Public Offering
Initial Public Offering
Number of units sold		30,000,000
Purchase price, per unit		$ 10
Proceeds received from initial public offering, gross		$ 300,000,000
Offering costs paid		(17,100,000)
Deferred underwriting costs		$ 10,500,000
Over-allotment option
Initial Public Offering
Number of units sold	1,000,000	4,500,000
Proceeds received from initial public offering, gross	$ 10,000,000
Offering costs paid	(550,000)
Deferred underwriting costs	$ 350,000
Class A Common Stock Not Subject to Redemption
Initial Public Offering
Number of shares in a unit				1
Number of shares issuable per warrant				1

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)	Mar. 16, 2021	Mar. 12, 2021	Jan. 23, 2021	Apr. 23, 2021
Over-allotment option
Related Party Transactions
Number of units sold	1,000,000	4,500,000
Class B Ordinary Shares
Related Party Transactions
Shares subject to forfeiture			1,125,000	875,000
Class B Ordinary Shares | Over-allotment option
Related Party Transactions
Shares subject to forfeiture	875,000
Number of units sold	1,000,000
Sponsor | Class B Ordinary Shares
Related Party Transactions
Expenses paid by Sponsor on behalf of the Company			$ 25,000
Number of shares issued			8,625,000
Shares subject to forfeiture			1,125,000	7,750,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20%
Aggregate number of shares owned				7,750,000
Restrictions on transfer period of time after business combination completion			1 year
Founder Shares | Sponsor | Class B Ordinary Shares
Related Party Transactions
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)			$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days

Related Party Transactions - Pr

Related Party Transactions - Private Placement Warrants (Details) - USD ($)			6 Months Ended
	Mar. 16, 2021	Mar. 12, 2021	Jun. 30, 2022	May 16, 2022
Related Party Transactions
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			30 days
Class A Common Stock Not Subject to Redemption
Related Party Transactions
Number of shares issuable per warrant			1
Class A Common Stock Not Subject to Redemption | Private Placement Warrants
Related Party Transactions
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Private Placement
Related Party Transactions
Price of warrants (in dollars per share)				$ 1.50
Private Placement | Private Placement Warrants
Related Party Transactions
Number of warrants to purchase shares issued		6,066,667
Price of warrants (in dollars per share)		$ 1.50
Proceeds from sale of Private Placement Warrants		$ 9,100,000
Over-allotment option | Private Placement Warrants
Related Party Transactions
Number of warrants to purchase shares issued	133,333
Price of warrants (in dollars per share)	$ 1.50
Proceeds from sale of Private Placement Warrants	$ 200,000

Related Party Transactions - Re

Related Party Transactions - Related Party Loans (Details) - USD ($)	Jun. 30, 2022	May 16, 2022	Dec. 31, 2021	Mar. 12, 2021
Related Party Transactions
Conversion Price Per Share		$ 1.50
Related Party Loans
Related Party Transactions
Maximum borrowing capacity of related party promissory note		$ 250,000		$ 300,000
Outstanding balance of related party note				$ 100,000
Related Party Loans | Working capital loans warrant
Related Party Transactions
Loan conversion agreement warrant	$ 1,500,000
Price of warrant	$ 1.50
Working Capital Loans			$ 0

Related Party Transactions - Ad

Related Party Transactions - Administrative Support Agreement (Details) - Administrative Support Agreement - USD ($)	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2022
Related Party Transactions
Expenses per month				$ 40,000
Expenses incurred and paid	$ 40,000	$ 120,000	$ 160,000	$ 160,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	Mar. 16, 2021 USD ($) $ / shares shares	Mar. 12, 2021 shares	Jun. 30, 2022 USD ($) item	Dec. 31, 2021 USD ($)
Commitments and Contingencies
Maximum number of demands for registration of securities | item			3
Underwriting cash discount per unit | $ / shares	$ 0.20
Underwriter cash discount	$ 6,000,000
Deferred fee per unit | $ / shares	$ 0.35
Aggregate deferred underwriting fee payable	$ 10,500,000
Underwriters' additional fees	200,000
Deferred underwriting commissions	$ 350,000
Contingent fees			$ 732,600	$ 732,600
Over-allotment option
Commitments and Contingencies
Overallotment option period		45 days
Number of units sold | shares	1,000,000	4,500,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details)	2 Months Ended	3 Months Ended		5 Months Ended	6 Months Ended
	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Less:
Fair value of Public Warrants at issuance		$ (1,653,330)	$ 4,960,000	$ 826,670	$ (7,274,660)
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount	$ 26,444,205
Class A Common Stock Subject to Redemption
Class A Ordinary Shares Subject to Possible Redemption
Temporary equity, shares authorized | shares		400,000,000			400,000,000
Temporary Equity, par value (in dollars per share) | $ / shares		$ 0.0001			$ 0.0001	$ 0.0001
Number of vote entitled to each share | Vote					1
Temporary equity, shares outstanding | shares		31,000,000			31,000,000	31,000,000
Components of Class A ordinary shares subject to possible redemption
Gross proceeds from Initial Public Offering and sale of Over-Allotment Units					$ 310,000,000
Less:
Fair value of Public Warrants at issuance					(9,300,000)
Offering costs allocated to Class A ordinary shares subject to possible redemption					(17,144,205)
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount					26,444,205
Class A ordinary shares subject to possible redemption		$ 310,000,000			310,000,000
Remeasurement accretion on Class A ordinary shares subject to possible redemption amount					342,804
Class A ordinary shares subject to possible redemption		$ 310,342,804			$ 310,342,804	$ 310,000,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares D shares	Dec. 31, 2021 shares	Mar. 16, 2021 $ / shares
Class A Common Stock Not Subject to Redemption
Derivative Warrant Liabilities
Number of trading days on which fair market value of shares is reported | D	10
Multiplier used in calculating warrant exercise price	0.361
Warrants
Derivative Warrant Liabilities
Number of warrants outstanding | shares	16,533,333	16,533,333
Private Placement Warrants
Derivative Warrant Liabilities
Number of warrants outstanding | shares	6,200,000	6,200,000
Restrictions on transfer period of time after business combination completion	30 days
Private Placement Warrants | Class A Common Stock Not Subject to Redemption
Derivative Warrant Liabilities
Exercise price of warrants			$ 11.50
Public Warrants
Derivative Warrant Liabilities
Number of warrants outstanding | shares	10,333,333	10,333,333
Warrant exercise period condition one	30 days
Warrant exercise period condition two	12 months
Public Warrants expiration term	5 years
Maximum period after business combination in which to file registration statement	20 days
Period of time within which registration statement is expected to become effective	60 days
Exercise price of warrants	$ 11.50
Share price trigger used to measure dilution of warrant	9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	60
Trading period after business combination used to measure dilution of warrant | D	20
Redemption period	30 days
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Derivative Warrant Liabilities
Warrant exercise price adjustment multiple	115
Warrant redemption condition minimum share price	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Redemption period	30 days
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Derivative Warrant Liabilities
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	180%
Warrant redemption condition minimum share price	$ 18
Warrant redemption condition minimum share price scenario two	10
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30

Shareholders' (Deficit) - Prefe

Shareholders' (Deficit) - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Shareholders' Deficit
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Shareholders' (Deficit) - Commo

Shareholders' (Deficit) - Common Stock Shares (Details)				6 Months Ended
	Mar. 16, 2021 shares	Mar. 12, 2021 shares	Jan. 23, 2021 shares	Jun. 30, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares	Apr. 23, 2021 shares
Shareholders' Deficit
Ratio to be applied to the stock in the conversion				1
Over-allotment option
Shareholders' Deficit
Number of units sold	1,000,000	4,500,000
Class A Common Stock Subject to Redemption
Shareholders' Deficit
Common shares, votes per share | Vote				1
Class A common stock subject to possible redemption, outstanding (in shares)				31,000,000	31,000,000
Class B Ordinary Shares
Shareholders' Deficit
Common shares, shares authorized (in shares)				40,000,000	40,000,000
Common shares, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Common shares, votes per share | Vote				1
Common shares, shares issued (in shares)			8,625,000	7,750,000	7,750,000
Common shares, shares outstanding (in shares)			8,625,000	7,750,000	7,750,000
Shares subject to forfeiture			1,125,000			875,000
Initial shareholders on issued and outstanding on ordinary shares			20%
Class B Ordinary Shares | Over-allotment option
Shareholders' Deficit
Number of units sold	1,000,000
Shares subject to forfeiture	875,000
Sponsor | Class B Ordinary Shares
Shareholders' Deficit
Shares subject to forfeiture			1,125,000			7,750,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair value hierarchy (Details) - USD ($)	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2022	Dec. 31, 2021
Liabilities:
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares			Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares	Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares
Change in fair value of derivative warrant liabilities	$ (1,653,330)	$ 4,960,000	$ 826,670	$ (7,274,660)
Recurring | Level 1 | Public Warrants
Liabilities:
Derivative warrant liabilities	2,066,670			2,066,670	$ 6,613,330
Recurring | Level 1 | Money Market Fund
Assets:
Investments held in Trust Account	310,442,804			310,442,804	310,016,344
Recurring | Level 2 | Private Placement Warrants
Liabilities:
Derivative warrant liabilities	$ 1,240,000			$ 1,240,000	$ 3,968,000

Fair Value Measurements - Quant

Fair Value Measurements - Quantitative information regarding Level 3 fair value measurements (Details)	Mar. 16, 2021 item Y	Mar. 12, 2021 item Y
Measurement Input, Stock price
Fair Value Measurements
Derivative warrant liabilities	9.70	9.70
Measurement Input, Volatility
Fair Value Measurements
Derivative warrant liabilities	0.140	0.140
Measurement Input, Term to M&A
Fair Value Measurements
Derivative warrant liabilities | Y	1	1
Measurement Input, Risk-free rate
Fair Value Measurements
Derivative warrant liabilities	0.0108	0.0108

Fair Value Measurements - Chang

Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)			5 Months Ended
	Mar. 16, 2021	Mar. 12, 2021	Jun. 30, 2021
Fair Value Measurements
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]			Fair Value Adjustment of Warrants
Level 3
Fair Value Measurements
Warrant liabilities at (inception)			$ 0
Issuance of Public and Private Placement Warrants at March 12, 2021		$ 14,460,000
Issuance of Public and Private Placement Warrants at March 16, 2021	$ 420,000
Change in fair value of derivative warrant liabilities			(4,133,330)
Transfer of Public Warrants to Level 1			(6,716,670)
Transfer of Private Placement Warrants to Level 2			(4,030,000)
Warrant liabilities at end of period			$ 0